Press Release: QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations

SAN DIEGO, Oct. 7, 2026 // -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of diagnostic solutions, has appointed Sanjeev Sharma, CFA, as Vice President, Investor Relations, effective September 28, 2026. Mr. Sharma brings more than 20 years of experience across investor relations, corporate strategy and equity research at global organizations. Most recently, he served as Senior Director of Investor Relations at Teva Pharmaceuticals, where he closely partnered with senior leadership to communicate the company's strategy and strengthen engagement with the investment community during a period of significant transformation. Previously, he spent more than a decade at Genpact in progressively senior roles across investor relations and business strategy. Earlier in his career, he spent nearly six years in sell-side equity research. Mr. Sharma holds a master's degree in finance and is a Chartered Financial Analyst (CFA). "We are pleased to welcome Sanjeev to QuidelOrtho," said Micah Young, Chief Financial Officer of QuidelOrtho. "He brings a valuable combination of investor relations leadership, healthcare experience, financial expertise and capital m